In an associated multicenter study, including 750 patients with MCI who were followed for at least two years, the conversion to AD could be predicted with a sensitivity of 83% and a specificity of 72% by the ratio of Aβ1-42/phospho-tau and total-tau. Here, MAPT is linked to Alzheimer disease.